PortfoliosLab logoPortfoliosLab logo
NUTX vs. SPY
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

NUTX vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nutex Health Inc (NUTX) and State Street SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

NUTX vs. SPY - Yearly Performance Comparison


2026 (YTD)2025202420232022
NUTX
Nutex Health Inc
-42.27%419.47%17.37%-90.53%-95.25%
SPY
State Street SPDR S&P 500 ETF
-4.37%17.72%24.89%26.18%-15.19%

Returns By Period

In the year-to-date period, NUTX achieves a -42.27% return, which is significantly lower than SPY's -4.37% return.


NUTX

1D
4.55%
1M
-13.96%
YTD
-42.27%
6M
-8.01%
1Y
102.08%
3Y*
-14.40%
5Y*
10Y*

SPY

1D
2.91%
1M
-4.94%
YTD
-4.37%
6M
-1.82%
1Y
17.59%
3Y*
18.19%
5Y*
11.69%
10Y*
13.98%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NUTX vs. SPY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NUTX
NUTX Risk / Return Rank: 7272
Overall Rank
NUTX Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
NUTX Sortino Ratio Rank: 7979
Sortino Ratio Rank
NUTX Omega Ratio Rank: 7474
Omega Ratio Rank
NUTX Calmar Ratio Rank: 7272
Calmar Ratio Rank
NUTX Martin Ratio Rank: 6464
Martin Ratio Rank

SPY
SPY Risk / Return Rank: 6464
Overall Rank
SPY Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
SPY Sortino Ratio Rank: 6060
Sortino Ratio Rank
SPY Omega Ratio Rank: 6565
Omega Ratio Rank
SPY Calmar Ratio Rank: 6565
Calmar Ratio Rank
SPY Martin Ratio Rank: 7575
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NUTX vs. SPY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nutex Health Inc (NUTX) and State Street SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NUTXSPYDifference

Sharpe ratio

Return per unit of total volatility

0.88

0.93

-0.04

Sortino ratio

Return per unit of downside risk

1.99

1.45

+0.53

Omega ratio

Gain probability vs. loss probability

1.24

1.22

+0.01

Calmar ratio

Return relative to maximum drawdown

1.54

1.53

+0.02

Martin ratio

Return relative to average drawdown

2.40

7.30

-4.89

NUTX vs. SPY - Sharpe Ratio Comparison

The current NUTX Sharpe Ratio is 0.88, which is comparable to the SPY Sharpe Ratio of 0.93. The chart below compares the historical Sharpe Ratios of NUTX and SPY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


NUTXSPYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.88

0.93

-0.04

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.69

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.78

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.48

0.56

-1.04

Correlation

The correlation between NUTX and SPY is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

NUTX vs. SPY - Dividend Comparison

NUTX has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.14%.


TTM20252024202320222021202020192018201720162015
NUTX
Nutex Health Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPY
State Street SPDR S&P 500 ETF
1.14%1.07%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%

Drawdowns

NUTX vs. SPY - Drawdown Comparison

The maximum NUTX drawdown since its inception was -99.93%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for NUTX and SPY.


Loading graphics...

Drawdown Indicators


NUTXSPYDifference

Max Drawdown

Largest peak-to-trough decline

-99.93%

-55.19%

-44.74%

Max Drawdown (1Y)

Largest decline over 1 year

-54.34%

-12.05%

-42.29%

Max Drawdown (5Y)

Largest decline over 5 years

-24.50%

Max Drawdown (10Y)

Largest decline over 10 years

-33.72%

Current Drawdown

Current decline from peak

-98.42%

-6.24%

-92.18%

Average Drawdown

Average peak-to-trough decline

-97.24%

-9.09%

-88.15%

Ulcer Index

Depth and duration of drawdowns from previous peaks

34.90%

2.52%

+32.38%

Volatility

NUTX vs. SPY - Volatility Comparison

Nutex Health Inc (NUTX) has a higher volatility of 24.94% compared to State Street SPDR S&P 500 ETF (SPY) at 5.31%. This indicates that NUTX's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


NUTXSPYDifference

Volatility (1M)

Calculated over the trailing 1-month period

24.94%

5.31%

+19.63%

Volatility (6M)

Calculated over the trailing 6-month period

73.87%

9.47%

+64.40%

Volatility (1Y)

Calculated over the trailing 1-year period

116.41%

19.05%

+97.36%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

135.16%

17.06%

+118.10%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

135.16%

17.92%

+117.24%